Epinephrine Market revenue to cross USD 4 Billion by 2033, says Research Nester
July 06, 2023 05:30 ET
|
Research Nester
New York, July 06, 2023 (GLOBE NEWSWIRE) -- The global epinephrine market is estimated to grow at a CAGR of ~12% from 2023 to 2033. The market is estimated to garner a revenue of ~USD 4 billion by...
Connected Drug Delivery Devices Market to hit USD 3.5 Billion by 2032, says Global Market Insights Inc.
April 05, 2023 06:10 ET
|
Global Market Insights Inc.
Selbyville, Delaware, April 05, 2023 (GLOBE NEWSWIRE) -- Connected drug delivery devices market value is anticipated to reach USD 3.5 billion by 2032, according to a new research report by Global...
Adamis Pharmaceuticals Corporation Issues Nationwide Voluntary Recall of SYMJEPI® (epinephrine) Injection for Potential Manufacturing Defect
March 21, 2022 16:05 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, March 21, 2022 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) is voluntarily recalling certain lots of SYMJEPI (epinephrine) Injection 0.15 mg (0.15 mg/0.3 mL) and...
Red Sneakers for Oakley Hosts Evening to Support Food Allergy Awareness at Club Colette in Palm Beach, FL
December 06, 2021 17:03 ET
|
Red Sneakers for Oakley
PALM BEACH, Fla., Dec. 06, 2021 (GLOBE NEWSWIRE) -- On Tuesday, November 23, Red Sneakers for Oakley hosted the sold-out Fourth Annual Fundraising Benefit at Club Colette to support food allergy...
Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events
August 24, 2021 16:05 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that David C. Benedicto, who has been serving as the Company’s Chief Accounting...
Adamis Pharmaceuticals Provides an Update on ZIMHI™
April 12, 2021 07:00 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, April 12, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided an update on the status of the company’s New Drug Application (NDA) relating to its...
Insights on the Auto-Injectors Global Market to 2026 - Featuring Antares Pharma, Mylan & Amgen Among Others
October 01, 2020 04:59 ET
|
Research and Markets
Dublin, Oct. 01, 2020 (GLOBE NEWSWIRE) -- The "Auto-Injectors Market Global Forecast by Regions, Application (Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Others), Product Types,...
Preventing Anaphylaxis
August 01, 2019 14:06 ET
|
The Jackson Laboratory
Farmington, Connecticut, Aug. 01, 2019 (GLOBE NEWSWIRE) -- An antibody, known as IgE, is the culprit in allergic reactions to everything from peanuts to tree pollen. A kind of super-antibody, known...
Global Autoinjectors Market is Set to Reach USD 4.5 Billion by 2024, Growing at a CAGR of 16.9% During the Forecast Period: VynZ Research
June 03, 2019 06:18 ET
|
VynZ Research
NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- The global autoinjectors market is predicted to grow at 16.9% CAGR during the forecast period with the market size reaching USD 4.5 billion by 2024. The...
Aegis is Awarded US Patent for Formulation and Non-invasive Delivery of Peptide Drugs
August 15, 2018 06:00 ET
|
Aegis Therapeutics LLC
SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Aegis Therapeutics LLC announced today that it has been awarded US Patent No. 10,046,025, providing non-invasive delivery of cyclic peptide drugs....